Your session is about to expire
← Back to Search
Diet Modification for Cardiovascular Health
N/A
Recruiting
Led By Kevin Davy, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45-minute measurement in the laboratory, 2 timepoints (baseline, 6 weeks post no or standard upf diet)
Awards & highlights
No Placebo-Only Group
Summary
This trial explores how reducing ultra-processed foods in middle-aged adults may improve their vascular health and reduce risks of CVD.
Who is the study for?
This trial is for middle-aged adults who are sedentary to moderately active, have a stable weight, and consume a diet with ultra-processed foods close to the US average. They must not plan on changing their diet or exercise routine and should be willing to eat provided food for 8 weeks. Exclusions include those with high cholesterol/triglycerides, BMI over 35, vegetarians/vegans, certain diseases, allergies or aversions to food, irregular bowel movements/laxative use, recent antibiotic/prebiotic/probiotic use.
What is being tested?
The study tests how cutting down on ultra-processed foods affects vascular health in middle-aged adults. Participants will follow either no UPF controlled diet or a standard UPF controlled diet for eight weeks while researchers monitor changes in vascular function and potential mechanisms like gut microbiota composition and inflammation.
What are the potential side effects?
Since this trial involves dietary changes rather than medication or invasive procedures, side effects may include digestive discomfort as the body adjusts to different levels of processed foods intake.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 45-minute measurement in the laboratory, 2 timepoints (baseline, 6 weeks post no or standard upf diet)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~45-minute measurement in the laboratory, 2 timepoints (baseline, 6 weeks post no or standard upf diet)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in brachial artery function from baseline to 6-weeks post no or standard UPF diet
Secondary study objectives
Change in arterial stiffness (Beta-stiffness index) from baseline to 6-weeks post no or standard UPF diet
Change in arterial stiffness (Carotid femoral pulse wave velocity) from baseline to 6-weeks post no or standard UPF diet
Change in endotoxin from baseline to post 6-weeks no or standard UPF diet
+5 moreOther study objectives
Change in 24-hour glucose control (24-hour mean) from baseline to 6-weeks post no or standard UPF diet
Change in 24-hour glucose control (AUC) from baseline to 6-weeks post no or standard UPF diet
Change in 24-hour glucose control (glycemic variability [GV]) from baseline to 6-weeks post no or standard UPF diet
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: No UPF (Ultra-processed foods)Experimental Treatment1 Intervention
Following a 2-week eucaloric lead-in diet, participants will be provided and consume a diet without UPF (0% energy) for 6 weeks. The controlled diet is eucaloric (50% carbohydrate, 35% fat,15% protein) matched for dietary soluble and insoluble fiber, added sugar, mono- and polyunsaturated fat, saturated fat, antioxidant nutrients, sodium, pre- and probiotics, and overall diet quality.
Participants will consume a diet containing 0% total energy from UPF for 6 weeks
Group II: High UPFExperimental Treatment1 Intervention
Following a 2-week eucaloric lead-in diet, participants will be provided and consume a diet composed of 59% UPF for 6 weeks. The controlled diet is eucaloric (50% carbohydrate, 35% fat,15% protein) matched for dietary soluble and insoluble fiber, added sugar, mono- and polyunsaturated fat, saturated fat, antioxidant nutrients, sodium, pre- and probiotics, and overall diet quality.
Find a Location
Who is running the clinical trial?
Virginia Polytechnic Institute and State UniversityLead Sponsor
156 Previous Clinical Trials
25,703 Total Patients Enrolled
Duke UniversityOTHER
2,463 Previous Clinical Trials
2,981,505 Total Patients Enrolled
Kevin Davy, PhDPrincipal InvestigatorVirginia Polytechnic Institute and State University
4 Previous Clinical Trials
74 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have diabetes or am taking medication for it.I have been diagnosed with inflammatory bowel disease.My blood pressure is controlled and below 160/100 mmHg with medication.I have been using cholesterol medication for less than 6 months.I have fewer than 3 bowel movements a week or regularly use laxatives.I have been on a stable dose of estrogen or testosterone for over 6 months.I have a history of heart, lung, blood, or metabolic diseases.I have not taken antibiotics or pre/probiotics in the last 3 months.I have been on the same dose of my cholesterol medication for over 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: High UPF
- Group 2: No UPF (Ultra-processed foods)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.